Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1996-3-19
|
| pubmed:abstractText |
The insulin-like growth factor system has recently been shown to have important mitogenic effects in the prostate. The system consists of 2 ligands: insulin-like growth factor types 1 and 2, which are potent mitogens for prostate cell growth, and 6 insulin-like growth factor binding proteins that modify the activity of these growth factors. Recently, changes in serum levels of insulin-like growth factor binding proteins 2 and 3 have been identified in prostate cancer patients but in vivo studies of these changes have not been previously reported.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0022-5347
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
155
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
999-1003
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8583626-Humans,
pubmed-meshheading:8583626-Immunohistochemistry,
pubmed-meshheading:8583626-Insulin-Like Growth Factor Binding Protein 1,
pubmed-meshheading:8583626-Insulin-Like Growth Factor Binding Protein 2,
pubmed-meshheading:8583626-Male,
pubmed-meshheading:8583626-Neoplasm Staging,
pubmed-meshheading:8583626-Prostate-Specific Antigen,
pubmed-meshheading:8583626-Prostatic Hyperplasia,
pubmed-meshheading:8583626-Prostatic Neoplasms
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: clinical correlations.
|
| pubmed:affiliation |
Department of Surgery (Urology), Madigan Army Medical Center, Tacoma, Washington 98431-5000, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|